Glucose-6-phosphate dehydrogenase deficiency and the use of primaquine: top-down and bottom-up estimation of professional costs.
Rev Saude Publica
; 51: 90, 2017 Oct 05.
Article
em En, Pt
| MEDLINE
| ID: mdl-29020124
ABSTRACT
The aim of this study has been to study whether the top-down method, based on the average value identified in the Brazilian Hospitalization System (SIH/SUS), is a good estimator of the cost of health professionals per patient, using the bottom-up method for comparison. The study has been developed from the context of hospital care offered to the patient carrier of glucose-6-phosphate dehydrogenase (G6PD) deficiency with severe adverse effect because of the use of primaquine, in the Brazilian Amazon. The top-down method based on the spending with SIH/SUS professional services, as a proxy for this cost, corresponded to R$60.71, and the bottom-up, based on the salaries of the physician (R$30.43), nurse (R$16.33), and nursing technician (R$5.93), estimated a total cost of R$52.68. The difference was only R$8.03, which shows that the amounts paid by the Hospital Inpatient Authorization (AIH) are estimates close to those obtained by the bottom-up technique for the professionals directly involved in the care.
Texto completo
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676719
- https://dx.doi.org/10.11606/S1518-8787.2017051007084
- http://www.scielo.br/scielo.php?script=sci_arttext&nrm=iso&lng=pt&tlng=pt&pid=S0034-89102017000100701
- http://www.scielosp.org/scielo.php?script=sci_arttext&nrm=iso&lng=pt&tlng=pt&pid=S0034-89102017000100701
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Primaquina
/
Custos Hospitalares
/
Deficiência de Glucosefosfato Desidrogenase
/
Hospitalização
/
Antimaláricos
Tipo de estudo:
Health_economic_evaluation
/
Prognostic_studies
País/Região como assunto:
America do sul
/
Brasil
Idioma:
En
/
Pt
Revista:
Rev Saude Publica
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Brasil